1832 Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-825,900
| Closed | -$48.3M | – | 714 |
|
|
2018
Q2 | $48.3M | Buy |
+825,900
| New | +$48.3M | 0.16% | 121 |
|
|
2017
Q3 | – | Sell |
-30,400
| Closed | -$1.31M | – | 727 |
|
|
2017
Q2 | $1.31M | Sell |
30,400
-21,800
| -42% | -$941K | 0.01% | 410 |
|
|
2017
Q1 | $1.64M | Sell |
52,200
-42,400
| -45% | -$1.33M | 0.01% | 423 |
|
|
2016
Q4 | $2.33M | Buy |
94,600
+39,000
| +70% | +$960K | ﹤0.01% | 484 |
|
|
2016
Q3 | $1.38M | Buy |
+55,600
| New | +$1.38M | 0.01% | 428 |
|